Results 11 to 20 of about 31,546 (239)

Serología en hepatitis virales = Serology in viral hepatitis

Iatreia, 2011
Cuando ocurre infección por el virus de hepatitis A (VHA), virus de hepatitits B (VHB), virus de hepatitis C (VHC) virus de hepatitis D o virus de hepatitis E (VHE) el cuadro clínico y bioquímico es similar, por lo que se hace necesario recurrir a ...
Jaramillo Aristizábal, María Clara, García Rendón, María Valentina, Restrepo Gutiérrez, Juan Carlos   +2 more
doaj   +1 more source

Antivirales de acción directa: la nueva era del tratamiento de la hepatitis C. Desde el interferón hasta la eliminación. [PDF]

, 2023
Hepatitis C virus (HCV) is a RNA virus, parenteral transmitted that, after an acute infection, becomes chronic in 75% of the cases. Chronic infection presents risk of cirrhosis progression and cirrhosis complications such as ascites, encephalopathy ...
Badia Aranda, Ester
core   +1 more source

Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. [PDF]

, 2010
Specific differences in signaling and antiviral properties between the different Lambda-interferons, a novel group of interferons composed of IL-28A, IL-28B and IL-29, are currently unknown.
Ralf Bartenschlager, Brand, Stephan, Burkhard Göke, Göke, Burkhard, Artur Kaul, Stephan Brand, Beigel, Florian, Kaul, Artur, Kathrin Zitzmann, Helmut M. Diepolder, Diegelmann, Julia, Diepolder, Helmut M., Christoph J Auernhammer, Bartenschlager, Ralf, Helmut M Diepolder, Christoph J. Auernhammer, Julia Diegelmann, Florian Beigel, Zitzmann, Kathrin, Auernhammer, Christoph J.   +19 more
core   +1 more source

Nuevos horizontes en la epidemiología, clínica, tratamiento y cribado de la infección por el virus de la hepatitis C en la era de los antivirales de acción directa

, 2022
La infecció pel virus de l'hepatitis C ha canviat radicalment després de l'aparició dels nous antivirals d'acció directa, fet que ha permès plantejar-se fins i tot l'eradicació de la infecció.
Llaneras Artigues, Jordi
core   +1 more source

Emerging Technologies for the Detection of Rabies Virus: Challenges and Hopes in the 21st Century [PDF]

, 2009
The diagnosis of rabies is routinely based on clinical and epidemiological information, especially when exposures are reported in rabies-endemic countries.
Müller, Thomas, Banyard, AC, Conrad M Freuling, Freuling, Conrad Martin, Dastjerdi, A., McElhinney, LM, Dastjerdi, A, Akbar Dastjerdi, Anthony R Fooks, Weiss, RA, Thomas Müller, Freuling, C.M., McElhinney, L.M., Edward Wright, Banyard, A.C., Lorraine M McElhinney, Fooks, AR, Johnson, N., Wright, E, Muller, T, Fooks, A.R., Wakeley, P.R., Wakeley, PR, Robin A Weiss, Philip R Wakeley, Johnson, N, Weiss, R.A., Marston, D.A., Muller, T., Marston, DA, Denise A Marston, Ashley C Banyard, Wright, E., Nicholas Johnson, Freuling, CM   +34 more
core   +1 more source

Hepatitis C crónica: aspectos clínicos, serológicos y de tratamiento en dos centros de atención en Bogotá, Colombia

Revista Colombiana de Gastroenterología, 2014
Introducción: el virus de la hepatitis C afecta a cerca de 170 millones de personas en el mundo. La organización mundial de la salud (OMS) estima una prevalencia mundial del 2%.
Jhon Edison Prieto Ortíz, Santiago Sánchez Pardo, Ever Leonardo Rojas Díaz, Sandra Judith Huertas Pacheco   +3 more
doaj   +1 more source

Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus

, 2008
Background The inhibitor telaprevir (VX-950) of the hepatitis C virus (HCV) protease NS3-4A has been tested in a recent phase 1b clinical trial in patients infected with HCV genotype 1. This trial revealed residue mutations that confer varying degrees of
Stefan Zeuzem, Albrecht, M., Hartmann, Christoph, Mayr, G., Andreas Schlicker, Welsch, C., Sarrazin, C., Susser, Simone, Sarrazin, Christoph, Lengauer, T., Albrecht, Mario, Christoph Welsch, Thomas Lengauer, Christoph Sarrazin, Antes, I., Mayr, Gabriele, Iris Antes, Simone Susser, Gabriele Mayr, Lengauer, Thomas, Susser, S., Zeuzem, S., Hartmann, C., Christoph Hartmann, Mario Albrecht, Schlicker, A., Francisco S Domingues, Domingues, Francisco S., Domingues, F., Welsch, Christoph, Schlicker, Andreas, Antes, Iris, Zeuzem, Stefan   +32 more
core   +1 more source

Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents

Anales de Pediatría (English Edition), 2019
Introduction: The aim of this study was to assess the safety and efficacy of ledipasvir/sofosbuvir combination in chronic Hepatitis C Virus (HCV) genotype 1 and 4 infection in paediatric patients.
Jesús Quintero, Javier Juampérez, Ecaterina Julio, Vanessa Cabello, Maria Mercadal-Hally, Pere Soler-Palacín, Óscar Segarra, Carlos Rodrigo   +7 more
doaj   +1 more source

Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation [PDF]

, 2019
Cholestatic hepatitis C (CHC) is a severe form of hepatitis C virus (HCV) infection recurrence that leads to high graft loss rates early after liver transplantation (LT).
Caro-Pérez, Noelia, Garcia-Cehic, D., Gambato, Martina, Crespo, Gonzalo, Gregori i Font, Josep, Ignacio Esteban, Juan, Navasa, Miquel, García-González, Neris, González-Candelas, Fernando, Quer, Josep, Pérez-Del-Pulgar, Sofía, Forns, Xavier, Koutsoudakis, George, González, Patricia   +13 more
core   +1 more source

Analysis of hepatitis C virus-positive organs in liver transplantation. [PDF]

, 2022
The authors of this study note that in liver transplantation (LT), the survival rates of hepatitis C virus (HCV)-positive donors and HCV-negative receivers are comparable to those of HCV-negative donors and recipients.
Legaz, Isabel, Legaz Pérez, Isabel, Muro, Manuel   +2 more
core   +1 more source